Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation
- 31 December 2009
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 158 (6), 902-909.e5
- https://doi.org/10.1016/j.ahj.2009.10.002
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trialThe Lancet, 2008
- Zotarolimus-Eluting Stents in Patients with Native Coronary Artery Disease: Clinical and Angiographic Outcomes in 1,317 PatientsThe American Journal of Cardiology, 2007
- Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent PlacementCirculation, 2006
- Two-Year-Plus Follow-Up of a Paclitaxel-Eluting Stent in De Novo Coronary Narrowings (TAXUS I)The American Journal of Cardiology, 2005
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005
- Late stent thrombosis after implantation of a sirolimus‐eluting stentCatheterization and Cardiovascular Interventions, 2003
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trialsBlood Pressure, 1992
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988